Evidence for positive selection in the extracellular domain of human cytomegalovirus encoded G protein-coupled receptor US28

Journal of Medical Virology

Volumn 83, Issue 7, 2011, Pages 1255-1261

  Gong, Xiaoyan ^a   Padhi, Abinash ^b  

^a WUHAN UNIVERSITY   (China)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Dual infection; HCMV; Molecular evolution; Polymorphisms; Positive selection

Indexed keywords

AMINO ACID; G PROTEIN COUPLED RECEPTOR; HUMAN CYTOMEGALOVIRUS ENCODED G PROTEIN COUPLED RECEPTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CODON; EXTRACELLULAR SPACE; GENETIC SELECTION; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNITY; LIGAND BINDING; NONHUMAN; NUCLEIC ACID ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; UNINDEXED SEQUENCE;

AMINO ACID SEQUENCE; BIOLOGICAL EVOLUTION; CHEMOKINES; CHINA; CODON; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EUROPE; HIV; HIV INFECTIONS; HUMANS; IMMUNE EVASION; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CHEMOKINE; RECEPTORS, G-PROTEIN-COUPLED; SELECTION, GENETIC; SIGNAL TRANSDUCTION; UNITED STATES; VIRAL PROTEINS;

HUMAN HERPESVIRUS 5;

EID: 79955888050     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22098     Document Type: Article

References (40)

1. Arav-Boger R, Willoughby RE, Pass RF, Zong JC, Jang WJ, Alcendor D, Hayward GS. 2002. Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J Infect Dis 186: 1057-1064.
2. Bodaghi B, Jones TR, Zipeto D, Vita C, Sun L, Laurent L, Arenzana-Seisdedos F, Virelizier JL, Michelson S. 1998. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: Withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 188: 855-866.
3. Bradley AJ, Kovacs IJ, Gatherer D, Dargan DJ, Alkharsah KR, Chan PK, Carman WF, Dedicoat M, Emery VC, Geddes CC, Gerna G, Ben-Ismaeil B, Kaye S, McGregor A, Moss PA, Pusztai R, Rawlinson WD, Scott GM, Wilkinson GW, Schulz TF, Davison AJ. 2008. Genotypic analysis of two hypervariable human cytomegalovirus genes. J Med Virol 80: 1615-1623.
4. Casarosa P, Menge WM, Minisini R, Otto C, van Heteren J, Jongejan A, Timmerman H, Moepps B, Kirchhoff F, Mertens T, Smit MJ, Leurs R. 2003. Identification of the first nonpeptidergic inverse agonist for a constitutively active viral-encoded G protein-coupled receptor. J Biol Chem 278: 5172-5178.
5. Casarosa P, Waldhoer M, LiWang PJ, Vischer HF, Kledal T, Timmerman H, Schwartz TW, Smit MJ, Leurs R. 2005. CC and CX3C chemokines differentially interact with the N terminus of the human cytomegalovirus-encoded US28 receptor. J Biol Chem 280: 3275-3285.
6. Cinatl J, Scholz M, Kotchetkov R, Vogel JU, Doerr HW. 2004. Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology. Trends Mol Med 10: 19-23.
7. de Oliveira T, Salemi M, Gordon M, Vandamme AM, van Rensburg EJ, Engelbrecht S, Coovadia HM, Cassol S. 2004. Mapping sites of positive selection and amino acid diversification in the HIV genome: An alternative approach to vaccine design? Genetics 167: 1047-1058.
8. Fernandez EJ, Lolis E. 2002. Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 42: 469-499.
9. Goffard A, Gault E, Rozenberg F, Moret N, Hober D, Deny P. 2006. Comparative sequence analysis of US28 gene of human cytomegalovirus strains isolated from HIV-positive patients. Virus Genes 33: 175-181.
10. Hedrick PW. 2007. Balancing selection. Curr Biol 17: R230-R231.
11. Hsich E, Zhou YF, Paigen B, Johnson TM, Burnett MS, Epstein SE. 2001. Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice. Atherosclerosis 156: 23-28.
12. Hubbell WL, Altenbach C, Hubbell CM, Khorana HG. 2003. Rhodopsin structure, dynamics, and activation: A perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. Adv Protein Chem 63: 243-290.
13. Kledal TN, Rosenkilde MM, Schwartz TW. 1998. Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28. FEBS Lett 441: 209-214.
14. Kunstman KJ, Puffer B, Korber BT, Kuiken C, Smith UR, Kunstman J, Stanton J, Agy M, Shibata R, Yoder AD, Pillai S, Doms RW, Marx P, Wolinsky SM. 2003. Structure and function of CC-chemokine receptor 5 homologues derived from representative primate species and subspecies of the taxonomic suborders Prosimii and Anthropoidea. J Virol 77: 12310-12318.
15. Librado P, Rozas J. 2009. DnaSP v5: A software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25: 1451-1452.
16. Martin DP, Williamson C, Posada D. 2005. RDP2: Recombination detection and analysis from sequence alignments. Bioinformatics 21: 260-262.
17. Metzger KJ, Thomas MA. 2010. Evidence of positive selection at codon sites localized in extracellular domains of mammalian CC motif chemokine receptor proteins. Bmc Evol Biol 10: 139-147.
18. Miller WE, Houtz DA, Nelson CD, Kolattukudy PE, Lefkowitz RJ. 2003. G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR. J Biol Chem 278: 21663-21671.
19. Mokros T, Rehm A, Droese J, Oppermann M, Lipp M, Hopken UE. 2002. Surface expression and endocytosis of the human cytomegalovirus-encoded chemokine receptor US28 is regulated by agonist-independent phosphorylation. J Biol Chem 277: 45122-45128.
20. Muhlestein JB, Horne BD, Carlquist JF, Madsen TE, Bair TL, Pearson RR, Anderson JL. 2000. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 102: 1917-1923.
21. Nei M. 1987. Molecular evolutionary genetics. New York: Columbia University Press.
22. Pignatelli S, Dal Monte P, Rossini G, Chou S, Gojobori T, Hanada K, Guo JJ, Rawlinson W, Britt W, Mach M, Landini MP. 2003. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: Identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol 84: 647-655.
23. Pleskoff O, Tréboute C, Brelot A, Heveker N, Seman M, Alizon M. 1997. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 276: 1874-1878.
24. Pleskoff O, Treboute C, Alizon M. 1998. The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins. J Virol 72: 6389-6397.
25. Pond SLK, Frost SDW. 2005. Datamonkey: Rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 21: 2531-2533.
26. Posada D, Crandall KA. 1998. Modeltest: Testing the model of DNA substitution. Bioinformatics 14: 817-818.
27. Rosenkilde MM, Smit MJ, Waldhoer M. 2008. Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors. Br J Pharmacol 153: S154-S166.
28. Ross SA, Boppana SB. 2005. Congenital cytomegalovirus infection: Outcome and diagnosis. Semin Pediatr Infect Dis 16: 44-49.
29. Schwartz TW, Frimurer TM, Holst B, Rosenkilde MM, Elling CE. 2006. Molecular mechanism of 7TM receptor activation-A global toggle switch model. Annu Rev Pharmacol Toxicol 46: 481-519.
30. Skrabanek L, Campagne F, Weinstein H. 2003. Building protein diagrams on the web with the residue-based diagram editor RbDe. Nucleic Acids Res 31: 3856-3858.
31. Soderberg-Naucler C. 2006. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 259: 219-246.
32. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. 2006. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 43: 1143-1151.
33. Stropes MP, Miller WE. 2008. Functional analysis of human cytomegalovirus pUS28 mutants in infected cells. J Gen Virol 89: 97-105.
34. Stropes MP, Schneider OD, Zagorski WA, Miller JL, Miller WE. 2009. The carboxy-terminal tail of human cytomegalovirus (HCMV) US28 regulates both chemokine-independent and chemokine-dependent signaling in HCMV-infected cells. J Virol 83: 10016-10027.
35. Swofford DL. 2002. PAUP*. Phylogenetic analysis using parsimony (* and other methods), version 4 b10. Massachusetts: Sinauer.
36. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
37. Waldhoer M, Casarosa P, Rosenkilde MM, Smit MJ, Leurs R, Whistler JL, Schwartz TW. 2003. The carboxyl terminus of human cytomegalovirus-encoded 7 transmembrane receptor US28 camouflages agonism by mediating constitutive endocytosis. J Biol Chem 278: 19473-19482.
38. Watterson GA. 1975. On the number of segregating sites in genetical models without recombination. Theor Popul Biol 7: 256-276.
39. Xia C, He R, Ruan Q, Guo JJ, Liu Q, Ji YH, Wei HB, Chen SR, Liu LQ. 2006. Polymorphisms of HCMV US28 gene of the clinical isolates from children. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 20: 23-25.
40. Yang ZH. 1997. PAML: A program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 13: 555-556.